Study S003390
A Real World Study of Lecanemab Treatment in Participants with Early Onset Familial Alzheimer's Disease
Registration
Registered primary outcomes
- Chang of CDR-SB score [baseline, 9 month, 18 month]
Linked records (0)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
No records link to this registration yet.